Journal
ADVANCED THERAPEUTICS
Volume 3, Issue 8, Pages -Publisher
WILEY
DOI: 10.1002/adtp.202000025
Keywords
microneedles; mTOR; parathyroid hormone; tendon healing; TGF-beta 1
Categories
Funding
- National Natural Science Foundation of China [81672146, 81873997, 81830076]
Ask authors/readers for more resources
Tendon rupture/defects may impose a huge economic and mental burden on patients and society. At present, neither surgery nor conservative treatment regimens can provide long-term therapeutic benefits, and the prognosis is often disappointing owing to the loss of tendon function and strength. There is an urgent need for innovative strategies to treat defective tendons. Here, a microneedle patch is developed for the efficient transdermal delivery of parathyroid hormone (PTH). The microneedle tip is made up of polyvinyl alcohol (PVA) and is water swellable, but insoluble, thereby ensuring the accurate and efficient release of PTH, while evacuating the skin without any tip material deposition. The PTH-loaded microneedle patch is replaced daily in a rat tendon defect-healing model. Results from histology, biomechanics, and gene expression analysis confirm that this newly developed microneedle patch accelerates tendon healing following the subcutaneous delivery of PTH and activates the transforming growth factor (TGF)-beta 1/mothers against decapentaplegic homolog 3 (Smad3)/mammalian target of rapamycin (mTOR) signaling cascade, which may be involved in the underlying mechanism. These results suggest that the PTH-loaded microneedle patch developed herein may serve as a novel therapeutic strategy for the treatment of injured tendons.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available